331
Views
51
CrossRef citations to date
0
Altmetric
Original Research

Development of nanoemulsion for efficient brain parenteral delivery of cefuroxime: designs, characterizations, and pharmacokinetics

, , , , &
Pages 2571-2584 | Published online: 27 Apr 2018

References

  • SwartzMNDodgePRBacterial meningitis – a review of selected aspectsN Engl J Med19652721577978714263639
  • HondaHWarrenDKCentral nervous system infections: meningitis and brain abscessInfect Dis Clin North Am200923360962319665086
  • MantenASide effects of antibioticsVet Q1981341791827292469
  • YılmazÇÖzcengizGAntibiotics: pharmacokinetics, toxicity, resistance and multidrug efflux pumpsBiochem Pharmacol2017133436227765485
  • PardridgeWMThe blood–brain barrier: bottleneck in brain drug developmentNeuroRx20052131410.1602/neurorx.2.1.315717053
  • ZivanovicLIvanovicIVladimirovSZecevicMInvestigation of chromatographic conditions for the separation of cefuroxime axetil and its geometric isomerJ Chromatogr B Analyt Technol Biomed Life Sci2004800175179
  • KossmannTHansVStockerRPenetration of cefuroxime into the cerebrospinal fluid of patients with traumatic brain injuryJ Antimicrob Chemother199637161167
  • NauRSörgelFEiffertHPenetration of drugs through the blood-cerebrospinal fluid/blood–brain barrier for treatment of central nervous system infectionsClin Microbiol Rev201023485888320930076
  • DateAANagarsenkerMSParenteral microemulsions : an overviewInt J Pharm2008355193018295991
  • LovelynCAttamaAACurrent state of nanoemulsions in drug deliveryJ Biomater Nanobiotechnol201125626639
  • WekslerBBSubileauEAPerrièreNBlood–brain barrier-specific properties of a human adult brain endothelial cell lineFASEB J200519131872187416141364
  • BariHA prolonged release parenteral drug delivery system – an overviewInt J Pharm Sci Rev Res201031111
  • PrabhakarKAfzalSMSurenderGKishanVTween 80 containing lipid nanoemulsions for delivery of indinavir to brainActa Pharm Sin B201335345353
  • AraújoFAKelmannRGAraújoBVFinattoRBTeixeiraHFKoesterLSEuropean Journal of Pharmaceutical Sciences Development and characterization of parenteral nanoemulsions containing thalidomideEur J Pharm Sci20114223824521130164
  • AvelliniLTerracinaLGaitiALinoleic acid passage through the blood–brain barrier and a possible effect of ageNeurochem Res19941921291338183422
  • MitchellRWOnNHDel BigioMRMillerDWHatchGMFatty acid transport protein expression in human brain and potential role in fatty acid transport across human brain microvessel endothelial cellsJ Neurochem2011117473574621395585
  • HsuJPNacuABehavior of soybean oil-in-water emulsion stabilized by nonionic surfactantJ Colloid Interface Sci2003259237438116256518
  • LuYZhangYYangZTangXFormulation of an intravenous emulsion loaded with a clarithromycin-phospholipid complex and its pharmacokinetics in ratsInt J Pharm20093661–216016918835427
  • SkouroliakouMKountouriAMHatziantoniouSKoutriKChiouAPhysicochemical stability assessment of all-in-one parenteral emulsion for neonates containing SMOFlipidBMJ201219514518
  • van HoogevestPWendelAThe use of natural and synthetic phospholipids as pharmaceutical excipientsEur J Lipid Sci Technol201411691088110725400504
  • FDA [webpage on the Internet]Inactive Ingredient Search for Approved Drug Products2010 Available from: https://www.accessdata.fda.gov/scripts/cder/iig/getiigWEB.cfmAccessed August 23, 2017
  • KoffieRMFarrarCTSaidiL-JWilliamCMHymanBTSpires-JonesTLNanoparticles enhance brain delivery of blood–brain barrier-impermeable probes for in vivo optical and magnetic resonance imagingProc Natl Acad Sci U S A201110846188371884222065785
  • WeissCKKohnleMLandfesterKHaukTThe first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood–brain barrier permeationChemMedChem200831395140318613205
  • KachelDLMoyerTPMartinWJAmiodarone-induced injury of human pulmonary artery endothelial cells: protection by alpha-tocopherolJ Pharmacol Exp Ther19902543110711122395108
  • GouletOAntebiHWolfCOriginal communicationJ Parenter Enter Nutr2010345485495
  • ZhangHYTangXLiHYLiuXLA lipid microsphere vehicle for vinorelbine: stability, safety and pharmacokineticsInt J Pharm20083481–2707917719191
  • BernardiDSPereiraTAMacielNRFormation and stability of oil-in-water nanoemulsions containing rice bran oil: in vitro and in vivo assessmentsJ Nanobiotechnology201194421952107
  • AnuchapreedaSFukumoriYOkonogiSIchikawaHPreparation of lipid nanoemulsions incorporating curcumin for cancer therapyJournal of Nanotechnology2012201211
  • MarkoutsaEPapadiaKClementeCFloresOAntimisiarisSGAnti-AB-MAb and dually decorated nanoliposomes: effect of AB1-42 peptides on interaction with hCMEC/D3 cellsEur J Pharm Biopharm2012811495622386910
  • PengJDongWJLiLEffect of high-pressure homogenization preparation on mean globule size and large-diameter tail of oil-in-water injectable emulsionsJ Food Drug Anal201523482883528911501
  • WangJJSungKCHuOYPYehCHFangJYSubmicron lipid emulsion as a drug delivery system for nalbuphine and its prodrugsJ Control Release2006115214014916959357
  • JoYJKwonYJCharacterization of β-carotene nanoemulsions prepared by microfluidization techniqueFood Sci Biotechnol2014231107113
  • LarssonMHillADuffyJSuspension stability; why particle size, zeta potential and rheology are importantAnnu Trans Nord Rheol Soc201220209214
  • ElsheikhMAElnaggarYSGoharEYAbdallahOYNanoemulsion liquid preconcentrates for raloxifene hydrochloride: optimization and in vivo appraisalInt J Nanomedicine20127378722888234
  • LevyMYBenitaSDesign and characterization of a submicronized o/w emulsion of diazepam for parenteral useInt J Pharm1989542103112
  • PichotRWatsonRNortonIPhospholipids at the interface: current trends and challengesInt J Mol Sci2013146117671179423736688
  • PatelRParenteral suspension: an overviewInt J Curr Pharm Res201023413
  • RoethlisbergerDMahlerH-CAltenburgerUPappenbergerAIf euhydric and isotonic do not work, what are acceptable ph and osmolality for parenteral drug dosage forms?J Pharm Sci2017106244645627889072
  • SchuhRSBruxelFTeixeiraHFPhysicochemical properties of lecithin-based nanoemulsions obtained by spontaneous emulsification or high-pressure homogenizationQuim Nova201437711931198
  • MattosCArgentaDMelchiadesGNanoemulsions containing a synthetic chalcone as an alternative for treating cutaneous leshmaniasis: optimization using a full factorial designInt J Nanomedicine201510552926366075
  • NilesALMoravecRARissTLIn vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screeningCurr Chem Genomics20093334120161834
  • AzeemARizwanMAhmadFJBrief/technical note nanoemulsion components screening and selection: a technical noteAAPS PharmSciTech2009101697619148761
  • WarisnoicharoenWLansleyABLawrenceMJToxicological evaluation of mixtures of nonionic surfactants, alone and in combination with oilJ Pharm Sci200392485986812661071
  • SalmelaLWashingtonCA continuous flow method for estimation of drug release rates from emulsion formulationsInt J Pharm20144721–227628124945139
  • KastelloriziosMBurgessDJIn vitro drug release testing and in vivo/in vitro correlation for long acting implants and injectionsLong Acting Injections and ImplantsBoston, MASpringer US2012475503
  • RitgerPLPeppasNAA simple equation for description of solute release II. Fickian and anomalous release from swellable devicesJ Control Release1987513742
  • BuyukozturkFBenneyanJCCarrierRLImpact of emulsion-based drug delivery systems on intestinal permeability and drug release kineticsJ Control Release20101421223019850092
  • GantaSAmijiMCoadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cellsMol Pharm200963503511
  • LiPLuWFood hydrocolloids effects of storage conditions on the physical stability of D-limonene nanoemulsionFood Hydrocolloids201653218224
  • JonesTNeustadterKPWhittinghamKWater-in-crude oil emulsion stability and emulsion destabilization by chemical this article begins on the next pageJ Can Pet197828100108
  • SetyaSTalegaonkarSRazdanBKISSN 2278 – 4357 nanoemulsions: formulation methods and stability aspectsWorld Journal of Pharmacy and Pharmaceutical Sciences20143222142228
  • ZainolSBasriMBasriHFormulation optimization of a palm-based nanoemulsion system containing levodopaInt J Mol Sci20121310130491306423202937
  • DeshpandeADBahetiKGChatterjeeNRDegradation of B-lactam antibioticsCurr Sci2004871216841695
  • TsaiTHChengFCChenKCChenYFChenCFSimultaneous measurement of cefuroxime in rat blood and brain by microdialysis and microbore liquid chromatography. Application to pharmacokineticsJ Chromatogr B Biomed Sci Appl19997351253110630887
  • WagnerSZensiAWienSLUptake mechanism of ApoE-modified nanoparticles on brain capillary endothelial cells as a blood–brain barrier modelPLoS One20127339
  • AlexisFPridgenEMolnarLKFarokhzadOCFactors affecting the clearance and biodistribution of polymeric nanoparticlesMol Pharm20085450551518672949
  • KalvassJCMaurerTSPollackGMUse of plasma and brain unbound fractions to assess the extent of brain distribution of 34 drugs: comparison of unbound concentration ratios to in vivo P-glycoprotein efflux ratiosDrug Metab Dispos200735466066617237155
  • JeffreyPSummerfieldSAssessment of the blood brain bariier in CNS drug discoveryNeurobiol Dis201037333710.1016/j.nbd.2009.07.03319664709
  • ReichelAAddressing central nervous system (CNS) penetration in drug discovery: basics and implications of the evolving new conceptChem Biodivers20096112030204919937839